Literature DB >> 28074460

Gender does not affect the prognosis of Fournier's gangrene: a case-matched study.

Pınar Sarkut, Özgen Işık, Ersin Öztürk1, Barış Gülcü, İlker Ercan, Tuncay Yılmazlar.   

Abstract

BACKGROUND: Female gender is accepted as a poor prognostic factor for Fournier's gangrene (FG). However, there is a paucity of data in the literature regarding this matter. This case-matched study was designed to investigate the impact of gender on outcomes of FG.
METHODS: Study patient data were retrieved from 120-patient, prospectively maintained database. Thirty-two female patients with FG were case-matched to 32 male patients based on symptom duration (days), FG severity index score, patient age, etiology, and presence of diabetes mellitus (DM) terms. Outcomes of FG were compared between the 2 groups.
RESULTS: Median age was 57 years (range: 22-80 years), and 35 (54.7%) patients had DM. Patients underwent average of 3 debridement procedures (range: 1-9 debridements), and 15 (23.4%) received diverting stoma. Overall mortality rate was 28.1% (18 of 64 patients). Female gender was associated with widespread disease (p=0.009), increased need for consecutive debridements (p=0.005), prolonged length of intensive care unit stay (p=0.035), and increased requirement for split-thickness skin graft reconstruction (p=0.040). However, mortality rates were comparable between genders (p=0.264).
CONCLUSION: FG is often more extensive in females and seems to be associated with anatomical features of female pelvis. However, female gender is not a factor affecting prognosis of patients with FG.

Entities:  

Mesh:

Year:  2016        PMID: 28074460     DOI: 10.5505/tjtes.2016.27095

Source DB:  PubMed          Journal:  Ulus Travma Acil Cerrahi Derg


  5 in total

1.  Hyperbaric Oxygenation in the Treatment of Fournier's Gangrene: A Systematic Review.

Authors:  Laila Schneidewind; Petra Anheuser; Sandra Schönburg; Florian M E Wagenlehner; Jennifer Kranz
Journal:  Urol Int       Date:  2020-12-07       Impact factor: 2.089

2.  [Contemporary practice patterns in the treatment of Fournier's gangrene in German academic medicine and their implications for planning a registry study].

Authors:  Jennifer Kranz; Florian M E Wagenlehner; Joachim Steffens; Oliver W Hakenberg; Laila Schneidewind
Journal:  Urologe A       Date:  2021-02-09       Impact factor: 0.639

3.  Fournier's Gangrene: Lessons Learned from Multimodal and Multidisciplinary Management of Perineal Necrotizing Fasciitis.

Authors:  Orestis Ioannidis; Loukiani Kitsikosta; Dimitris Tatsis; Ioannis Skandalos; Aggeliki Cheva; Aikaterini Gkioti; Ioannis Varnalidis; Savvas Symeonidis; Natalia Antigoni Savvala; Styliani Parpoudi; George K Paraskevas; Manousos George Pramateftakis; Efstathios Kotidis; Ioannis Mantzoros; Konstantinos George Tsalis
Journal:  Front Surg       Date:  2017-07-10

4.  Management of Fournier's gangrene during the Covid-19 pandemic era: make a virtue out of necessity.

Authors:  Alessio Paladini; Giovanni Cochetti; Angelica Tancredi; Matteo Mearini; Andrea Vitale; Francesca Pastore; Paolo Mangione; Ettore Mearini
Journal:  Basic Clin Androl       Date:  2022-07-19

5.  Desperate need for better management of Fournier's gangrene.

Authors:  Jennifer Kranz; Daniel Schlager; Petra Anheuser; Sandra Mühlstädt; Benedict Brücher; Tanja Frank; Dimitri Barski; Roman Mayr; Andreas Lunacek; Eric Francis Macharia-Nimietz; Joachim A Steffens; Johannes Grolle; Alexandre Pelzer; Laila Schneidewind
Journal:  Cent European J Urol       Date:  2018-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.